查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016656

分叉病變市場報告：按類型、應用和地區分類，2026-2034 年

Bifurcation Lesions Market Report by Types (One-Stent, Two-Stent), Application (Coronary Vascular, Peripheral Vascular), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025 年全球分叉病變市場規模達 26 億美元。展望未來，IMARC 集團預測，到 2034 年，市場規模將達到 39 億美元，2026 年至 2034 年的複合年成長率為 4.22%。

分叉病變是指冠狀動脈在主要側支血管（SBs）起始處附近的狹窄。由於湍流和高剪切應力，這些區域容易形成動脈粥狀硬化斑塊。治療方法包括分析、治療時間、X光照射和長期追蹤等。此外，3D血管造影術和多切面CT用於測量分叉角度。器械、影像學、輔助藥物治療和血管通路技術的進步使得複雜分叉病變的治療在全球範圍內成為可能。

分叉病變市場的發展趨勢：

冠狀動脈疾病（CAD）發生率的顯著上升增加了發生分叉病變的風險，這是市場成長的主要促進因素之一。此外，創新醫療設備的核准、保險覆蓋範圍的擴大以及診斷影像技術的進步也推動了市場成長。老年人口的成長（老年人更容易生病）以及世界各國政府的報銷支持措施也促進了市場成長。醫療旅遊的興起、對微創手術（MI）需求的成長以及醫療基礎設施的改善也是推動市場成長的其他因素。此外，對新型治療技術的持續研究也正在推動市場發展。例如，研究人員正在研究Szabo 2支架法治療複雜分叉病變的有效性，這類病變由於側支血管閉塞，併發症風險高，甚至可能導致致命後果。此外，大量關於支架和球囊的臨床試驗，以及熟練醫療專業人員的增加，有望降低治療分叉病變的風險，並對市場產生積極影響。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球分叉病變市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 單支架
  • 兩個支架

第7章 市場區隔：依應用領域分類

  • 冠狀動脈
  • 周邊血管

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Boston Scientific Corporation
    • Cardinal Health
    • Medtronic plc
    • Spectranetics（Koninklijke Philips NV）
    • Terumo Corporation
Product Code: SR112026A4003

The global bifurcation lesions market size reached USD 2.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4.22% during 2026-2034.

A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.

BIFURCATION LESIONS MARKET TRENDS:

A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.

KEY MARKET SEGMENTATION:

Breakup by Types:

  • One-Stent
  • Two-Stent

Breakup by Application:

  • Coronary Vascular
  • Peripheral Vascular

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global bifurcation lesions market in 2025?

2. What is the expected growth rate of the global bifurcation lesions market during 2026-2034?

3. What has been the impact of COVID-19 on the global bifurcation lesions market?

4. What are the key factors driving the global bifurcation lesions market?

5. What is the breakup of the global bifurcation lesions market based on the application?

6. What are the key regions in the global bifurcation lesions market?

7. Who are the key players/companies in the global bifurcation lesions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bifurcation Lesions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Types

  • 6.1 One-Stent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Two-Stent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Vascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Peripheral Vascular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Boston Scientific Corporation
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Cardinal Health
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Medtronic plc
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Spectranetics (Koninklijke Philips N.V.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Terumo Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bifurcation Lesions Market: Major Drivers and Challenges
  • Figure 2: Global: Bifurcation Lesions Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Bifurcation Lesions Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Bifurcation Lesions Market: Breakup by Types (in %), 2025
  • Figure 5: Global: Bifurcation Lesions Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Bifurcation Lesions Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Bifurcation Lesions (One-Stent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Bifurcation Lesions (One-Stent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Bifurcation Lesions (Two-Stent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Bifurcation Lesions (Two-Stent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Bifurcation Lesions (Coronary Vascular) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Bifurcation Lesions (Coronary Vascular) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Bifurcation Lesions (Peripheral Vascular) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Bifurcation Lesions (Peripheral Vascular) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: North America: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: North America: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: United States: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: United States: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Canada: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Canada: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Asia-Pacific: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Asia-Pacific: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: China: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: China: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Japan: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Japan: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: India: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: India: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: South Korea: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: South Korea: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Australia: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Australia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Indonesia: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Indonesia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Europe: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Europe: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Germany: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Germany: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: France: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: France: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: United Kingdom: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: United Kingdom: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Italy: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Italy: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Spain: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Spain: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Russia: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Russia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Latin America: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Latin America: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Brazil: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Brazil: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Mexico: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Mexico: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Middle East and Africa: Bifurcation Lesions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Middle East and Africa: Bifurcation Lesions Market: Breakup by Country (in %), 2025
  • Figure 63: Middle East and Africa: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Global: Bifurcation Lesions Industry: SWOT Analysis
  • Figure 65: Global: Bifurcation Lesions Industry: Value Chain Analysis
  • Figure 66: Global: Bifurcation Lesions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bifurcation Lesions Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Bifurcation Lesions Market Forecast: Breakup by Types (in Million USD), 2026-2034
  • Table 3: Global: Bifurcation Lesions Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Bifurcation Lesions Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Bifurcation Lesions Market: Competitive Structure
  • Table 6: Global: Bifurcation Lesions Market: Key Players